Clinical Updates
Drug approvals, guideline changes, and treatment advances
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
More form Clinical Updates
FDA Issues Correction Notice for TRUE METRIX Blood Glucose Monitors Over Error Code Risk
Trividia Health has issued a correction notice for TRUE METRIX blood glucose monitors after reports…
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight…